Last reviewed · How we verify
Plaque psoriasis — Treatment Landscape & Competitive Intelligence
10 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Sotyktu | DEUCRAVACITINIB | Bristol-Myers Squibb | Tyrosine Kinase 2 Inhibitor [EPC] | Non-receptor tyrosine-protein kinase TYK2 | 2022-01-01 | |
| Bimzelx | BIMEKIZUMAB | Ucb Japan Co., Ltd. | Interleukin-17A | 2021-01-01 | ||
| Skyrizi | RISANKIZUMAB | AbbVie | Interleukin-23 Antagonist [EPC] | Interleukin-23 subunit alpha | 2019-01-01 | |
| Sunpg 1622 | TILDRAKIZUMAB | Sun Pharma Global | Interleukin-23 Antagonist [EPC] | Interleukin-23 | 2018-01-01 | |
| Kyntheum | BRODALUMAB | Valeant Luxembourg | Interleukin-17 Receptor A Antagonist [EPC] | Interleukin-17 receptor | 2017-01-01 | |
| Tremfya | GUSELKUMAB | Johnson & Johnson | Interleukin-23 Antagonist [EPC] | p19 subunit of IL-23 | 2017-01-01 | |
| Taltz | ixekizumab | Eli Lilly | Interleukin-17A antagonist | Interleukin 17A (IL-17A) cytokine | 2016-01-01 | |
| Cosentyx | secukinumab | Novartis | IL-17A antagonist | Interleukin-17A (IL-17A) | 2015-01-01 | |
| Otezla | APREMILAST | Amgen | Phosphodiesterase 4 Inhibitor [EPC] | PDE4 | 2014-01-01 | |
| Tecfidera | DIMETHYL FUMARATE | Biogen | dimethyl fumarate | Hydroxycarboxylic acid receptor 2 | 2013-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
- — Topicort · FDA · approved · US
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 10 drugs in Plaque psoriasis
- Johnson & Johnson · 5 drugs in Plaque psoriasis
- Pfizer · 5 drugs in Plaque psoriasis
- AbbVie · 3 drugs in Plaque psoriasis
- Astellas Pharma · 2 drugs in Plaque psoriasis
- Merck & Co. · 2 drugs in Plaque psoriasis
- Bausch Health · 2 drugs in Plaque psoriasis
- Biogen · 1 drug in Plaque psoriasis
- AstraZeneca · 1 drug in Plaque psoriasis
- Biocon Biologics UK Ltd · 1 drug in Plaque psoriasis
- Biocad · 1 drug in Plaque psoriasis
- Arcutis · 1 drug in Plaque psoriasis
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Plaque psoriasis:
- Plaque psoriasis treatment updates — RSS
- Plaque psoriasis treatment updates — Atom
- Plaque psoriasis treatment updates — JSON
Cite this brief
Drug Landscape (2026). Plaque psoriasis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/plaque-psoriasis. Accessed 2026-06-10.
Related
- Plaque psoriasis full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing